TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from XBiotech ( (XBIT) ).
XBiotech Inc. has appointed Dr. Tak W. Mak to its Board of Directors, filling an existing vacancy. Dr. Mak, a distinguished scientist known for his groundbreaking work in immunology, will serve until the next annual general meeting. His contributions to the field, including the identification of the immune checkpoint inhibitor CTLA-4, have significantly impacted oncology therapeutics. This appointment is expected to enhance XBiotech’s leadership and innovation in the industry.
More about XBiotech
YTD Price Performance: 2.25%
Average Trading Volume: 61,993
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $124.7M
Learn more about XBIT stock on TipRanks’ Stock Analysis page.